Brief: Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology
18/10/2023 13:55
Oct 18 (Reuters) - Yield10 Bioscience Inc YTEN.O :
* YIELD10 BIOSCIENCE EXERCISES OPTION TO FINALIZE AN
EXCLUSIVE,
GLOBAL COMMERCIAL LICENSE TO ADVANCED OMEGA-3 CAMELINA
TECHNOLOGY FROM ROTHAMSTED RESEARCH
Source text for Eikon: ID:nGNX5j800r
Further company coverage: YTEN.O
((Reuters.Briefs@thomsonreuters.com;))